The COVID-19 pandemic has presented challenges and opportunities for substance disorder treatment. IRETA and Vital Strategies are studying effects of OTP rule changes.
Addiction
Skyrocketing Methamphetamine Overdose Deaths Show Our “Crisis Response” Must Expand Beyond Just Opioids
The National Institutes of Health (NIH) released a study that shows a combination of two medications, injectable naltrexone and oral bupropion, is safe and effective in treating methamphetamine use disorder.
A New Service Delivery Model: How IRETA has Adapted Clinical Quality Improvement in the Era of COVID
IRETA faced the challenge of switching completely to telehealth with very little notice. IRETA’s Director of Clinical Quality Improvement Services, David Reazin, MHS, answered questions about what it was like to adapt to telehealth and the pros and cons of virtual groups.
Compassion Fatigue: A Personal Account from an IRETA Clinical Quality Improvement Associate
I don’t believe that we can truly understand what those teachers lecturing about clinician burnout means until we’re “in the trenches” of this field. Let’s talk about compassion fatigue.
Questioning Alcohol Use as “#SelfCare”: The Sober Curious Movement and Being Mindful About Alcohol Consumption
Questioning Alcohol Use as “#SelfCare.” When it comes to sleep, alcohol may help you fall asleep, but it actually disrupts sleep patterns and blocks REM sleep, causing anyone who drinks it before bed to have a less restful night’s sleep than if they hadn’t consumed alcohol.
